Corrigendum: The differential short- and long-term effects of HIV-1 latency-reversing agents on T cell function

Autor: G. Clutton, Y. Xu, P. L. Baldoni, K. R. Mollan, J. Kirchherr, W. Newhard, Kara Cox, J. D. Kuruc, A. Kashuba, R. Barnard, N. Archin, C. L. Gay, M. G. Hudgens, D. M. Margolis, N. Goonetilleke

Publikováno v: Scientific Reports

Despite the extraordinary success of HIV-1 antiretroviral therapy in prolonging life, infected individuals face lifelong therapy because of a reservoir of latently-infected cells that harbor replication competent virus. Recently, compounds have been

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e38a8f5e048ab04c3f8fc8a433191df
https://pubmed.ncbi.nlm.nih.gov/27480951

A Markov model for measuring vaccine efficacy for both susceptibility to infection and reduction in infectiousness for prophylactic HIV vaccines

Autor: I M, Longini, M G, Hudgens, M E, Halloran, K, Sagatelian

Publikováno v: Statistics in medicine. 18(1)

We use a discrete-time non-homogeneous Markov chain to model data from augmented human immunodeficiency virus (HIV) vaccine trials. For this design, the study population consists of primary participants some of whom have steady sexual partners who ar

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::24482b7c8dafe8e2f9557406431200b6
https://pubmed.ncbi.nlm.nih.gov/9990692

CD3 downregulation identifies high-avidity human CD8 T cells.

Autor: Clutton GT; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Weideman AMK; Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Mischell MA; Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Kallon S; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Conrad SZ; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Shaw FR; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Warren JA; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Lin L; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Kuruc JD; Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Xu Y; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Gay CM; Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Armistead PM; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., G Hudgens M; Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Goonetilleke NP; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Publikováno v: Clinical and experimental immunology [Clin Exp Immunol] 2024 Feb 19; Vol. 215 (3), pp. 279-290.